About US
Contact us
-
European regulators tag 100-plus drugs with 'black triangle'The European Medicines Agency has rolled out its list of drugs that soon will bear the "black triangle." The labeling logo is designed to encourage doctors and patients to report side effects, as par2013/4/26
-
Is GlaxoSmithKline prepping older products for spinoff?GlaxoSmithKline's waiting game continues. The U.K.-based drugmaker ($GSK) posted disappointing profits for the first quarter as sales took a backwards step, partly because of revenue lost in the sale2013/4/25
-
Merck nabs 'breakthrough' label for anti-melanoma drugMerck ($MRK) won the FDA's "Breakthrough Therapy" tag for its experimental antibody drug lambrolizumab, aimed at advanced melanoma. The designation was based on Phase Ib data that showed significant2013/4/25
-
Drugmakers, get ready for bigger, faster dealmaking, Moody's saysDeal junkies, rejoice. Moody's Investors Service figures pharma M&A will pick up in 2013, after a not-so-exciting 2012. But even if the pace picks up, deal size probably won't increase much; we'r2013/4/24
-
Biogen MS pill soars onstage with impressive first-week script numbersBiogen Idec's ($BIIB) newmultiple sclerosispill made its debut to high expectations earlier this month. And so far, Tecfidera hasn't disappointed. AsThe Streetreports, the drug has literally leapt on2013/4/24
-
New tool for live cell imaging launchedA new tool for live cell imaging has been announced by Cellectis bioresearch - a subsidiary of Cellectis Group. VizuCELL cell lines is set to help with the study of temporal and spatial dynamic proces2013/4/23
-
AstraZeneca inks cancer deals with Bind Therapeutics, Horizon DiscoveryAstraZeneca ($AZN) forged two oncology development deals on either side of the Atlantic. It teamed up with the U.K.'s Horizon Discovery on a program to target K-Ras mutant tumors, and tapped Bind The2013/4/23
-
First implantation of resorbable antibacterial envelope announcedThe first ever implantation of a fully resorbable antibacterial envelope has taken place to help ensure surgery patients are at a lower risk of infection. According to TYRX, the AIGISRx R antibacteri2013/4/22
-
Hated German price formula to be applied to Pradaxa, Prolia, other drugsDrugmakers, livid with German pricing gatekeepers for turning down so many new drugs, now face a strategy that is sure to ratchet up their anger to the boiling point. The agency has started a review2013/4/22
-
Hikma decides injectables drug business a prize to hold ontoWhen Mylan agreed to pay $1.6 billion to nab Strides Arcolab's sterile injectables drug business, the competitors it bested were thought to be sniffing around elsewhere for a similar deal. Within d2013/4/19